Log In
Print
BCIQ
Print
Print this Print this
 

tolterodine/pilocarpine (Tolenix) (THVD-201)

  Manage Alerts
Collapse Summary General Information
Company TheraVida Inc.
DescriptionModified-release formulation of tolterodine and pilocarpine
Molecular Target Muscarinic receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB) and urge urinary incontinence
Regulatory Designation

Partner

SK Chemicals Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today